Haematosalpinx/Haematoma of broad ligament

N14_MAEMABROAD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N83.6, N83.7 Hospital discharge: ICD-9 — 6207 Cause of death: ICD-10 — N83.6, N83.7 Cause of death: ICD-9 — 6207 2 out of 7 registries used, show all original rules.	71
4. Check minimum number of events None	71
5. Include endpoints None	71
6. Filter based on genotype QC (FinnGen only)	65

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENNONINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_MAEMABROAD
CONTROL_EXCLUDE	N14_FEMALEGENNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N836\|N837
HD_ICD_9	6207
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N836\|N837
COD_ICD_9	6207
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Haematosalpinx/Haematoma of broad ligament based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	390	390	-
Only index persons	377	377	-
Unadjusted period prevalence (%)
Whole population	0.01	0.01	-
Only index persons	0.01	0.01	-
Median age at first event (years)
Whole population	-	39.54	-
Only index persons	-	39.34	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65	65	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	39.35	39.35	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
71: Matched controls
710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N83.6

ICD-10 Finland

Haematosalpinx

+∞

57.2

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

70.7

29.0

N83.7

ICD-10 Finland

Haematoma of broad ligament

+∞

20.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

7.8

17.2

117

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

7.1

15.6

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

+∞

15.1

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

18.0

12.9

N95.1

ICD-10 Finland

Menopausal and female climacteric states

+∞

10.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

4.9

10.2

154

JAH01

NOMESCO Finland

Laparoscopy

26.0

9.8

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

9.2

9.0

N81.6

ICD-10 Finland

Rectocele

101.6

8.6

N80.1

ICD-10 Finland

Endometriosis of ovary

101.6

8.6

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

+∞

8.5

N84.0

ICD-10 Finland

Polyp of corpus uteri

+∞

8.5

N83.1

ICD-10 Finland

Corpus luteum cyst

+∞

7.4

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

+∞

7.4

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

3.9

7.2

227

TLC00

NOMESCO Finland

Insertion of intrauterine device

12.8

7.1

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

20.3

6.4

N97.8

ICD-10 Finland

Female infertility of other origin

+∞

6.3

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

+∞

6.3

N97.1

ICD-10 Finland

Female infertility of tubal origin

+∞

6.3

N02AX02

ATC

tramadol; systemic, rectal

3.5

6.2

170

LCA06

NOMESCO Finland

Biopsy of endometrium

8.1

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

9.77

5.80

2.7

1.5

53.18

98.00

pmol/l

0.45

(3037467) Urinalysis macro (dipstick) panel - Urine

348

3.88

5.53

4.6

3.5

—

(3026008) Bacteria identified in Urine by Culture

140

2.65

3.67

2.5

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4.62

3.57

1.1

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

103

2.65

3.24

1.9

1.8

0.45

0.75

mg/l

1.23

(3019150) Specific gravity of Urine by Refractometry

111

2.59

3.18

5.8

3.1

1.02

kg/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

136

2.44

3.03

2.3

51.92

57.88

u/l

0.64

127

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.04

3.00

1.4

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.09

2.90

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

8.84

2.79

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.73

2.54

1.3

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

171

2.18

2.49

2.8

3.3

24.34

28.58

u/l

0.68

165

(40768804) Tissue Pathology biopsy report

215

2.12

2.43

2.3

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

6.62

2.41

4.2

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

126

2.22

2.34

1.6

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

245

2.07

2.31

2.2

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

112

2.24

2.27

1.3

2.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

5.88

2.25

1.4

2.2

12.26

13.41

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

250

2.00

2.14

3.4

6.0

8.81

9.04

umol/l

0.06

239

(3019060) Gas panel - Arterial blood

3.76

2.11

6.1

4.9

—

(3042936) Bacteria identified in Isolate by Culture

2.41

2.10

1.5

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

192

1.97

1.99

4.9

2.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4.80

1.97

1.0

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

4.80

1.97

1.6

1.0

—

(40768797) Stomach Pathology biopsy report

2.52

1.93

1.3

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.59

1.88

6.0

5.6

102.91

105.19

mmol/l

0.39

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.71

1.81

1.6

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.71

1.81

1.6

—

(4200892) Spirometry reversibility

3.12

1.77

1.4

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

148

1.94

1.74

1.3

2.0

—

(3002256) Pathology report gross observation

2.47

1.74

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.87

1.62

5.9

6.0

0.74

0.59

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.87

1.62

5.9

6.0

1.37

1.33

—

(3023511) Choriogonadotropin [Units/volume] in Urine

3.18

1.62

1.3

1.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.76

1.56

5.9

5.8

95.76

95.01

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

3.50

1.55

1.2

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

3.50

1.55

1.0

1.9

—

4.90

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

147

1.84

1.47

1.7

2.7

10.93

18.17

ng/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2.27

1.47

1.6

1.3

87.33

127.60

iu/ml

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.88

1.47

6.8

4.2

—

(3022621) pH of Urine by Test strip

2.56

1.43

2.3

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.31

1.41

1.4

2.3

2.80

4.03

umol/l

—

(1002224) Polysomnography panel

3.08

1.38

1.0

—

(3023368) Bacteria identified in Blood by Culture

1.91

1.31

2.7

3.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2.75

1.23

4.8

5.9

25.10

23.95

mmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

113

1.79

1.20

3.8

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

191

1.67

1.20

9.5

7.9

1.13

1.09

inr

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1.91

1.19

3.7

2.6

68.78

89.38

ng/l

—

(40761535) Cells panel - Urine sediment

2.12

1.16

4.3

3.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.48

1.16

1.7

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.88

1.15

1.9

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.98

0.0

1.7

—

2.83

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2.02

0.92

1.3

1.8

—

(1761868) Lipid panel - Serum or Plasma

240

0.62

0.92

1.4

2.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.97

0.91

2.4

3.6

4.54

4.60

pmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.69

0.86

2.2

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

411

1.52

0.84

4.9

3.4

9.87

10.21

mm/h

0.10

383

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

182

1.48

0.75

1.8

1.7

99.20

92.92

pmol/l

—

(36660697) Celiac disease serology panel - Serum

1.64

0.63

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

0.61

0.0

2.0

—

1.55

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

125

1.47

0.61

1.7

2.0

122.47

178.01

u/l

0.39

117

(3000492) Spirometry study

1.57

0.61

1.9

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.56

0.61

1.8

1.5

430.00

98649074.03

pmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.54

0.59

1.5

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.59

0.0

2.9

—

22.74

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.49

0.55

4.7

3.1

27.78

32.86

—

(4035726) Immunohistochemistry procedure

1.59

0.54

1.2

1.4

—

(3013512) EKG study

119

1.44

0.54

2.2

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

128

1.43

0.54

1.6

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

582

1.51

0.49

15.2

9.1

29.86

19.75

mg/l

1.14

420

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

539

1.42

0.46

10.5

8.5

88.54

87.52

ml/min/173m2

0.15

416

(40760892) CBC W Ordered Manual Differential panel - Blood

245

1.31

0.46

3.5

5.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

133

1.37

0.44

4.8

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.55

0.42

2.0

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.51

0.41

1.4

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.41

0.0

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.40

0.0

2.0

—

0.63

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.39

0.0

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.39

0.0

2.1

—

43.06

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

0.00

0.39

0.0

2.0

—

24.04

—

(3019225) pH of Specimen

1.42

0.39

3.0

4.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

155

1.31

0.37

1.7

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.51

0.37

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

1.40

0.35

1.0

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.36

0.35

2.0

2.4

20.00

21.49

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

138

1.30

0.34

1.7

—

(3018095) Leukocytes [#/volume] in Urine

140

1.28

0.31

3.1

2.8

8.79

64.40

e6/l

1.60

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.33

0.29

1.8

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.24

0.28

1.4

1.6

—

(40761511) CBC panel - Blood by Automated count

627

1.43

0.25

12.1

8.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

565

1.26

0.24

14.2

9.8

139.58

139.82

mmol/l

0.27

548

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.27

0.23

1.2

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.21

0.0

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

1.7

—

1.45

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

567

1.24

0.21

14.1

9.8

3.92

mmol/l

0.02

548

(3050129) First trimester maternal screen panel - Serum or Plasma

1.27

0.21

1.7

1.5

—

(3044889) 12 lead EKG panel

353

1.16

0.20

3.6

2.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

138

1.21

0.19

4.1

2.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.23

0.19

1.6

2.3

11.14

14.42

umol/l

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

633

1.32

0.16

9.2

8.0

21.82

24.11

u/l

0.87

610

(3003694) ABO and Rh group [Type] in Blood

170

0.85

0.16

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

0.79

0.15

1.1

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

122

1.18

0.15

3.7

1.44

14.60

mg/mmol

—

(36304419) Bacteria [Presence] in Urine

104

1.19

0.13

3.4

2.5

—

(3012516) Albumin [Mass/volume] in Urine

114

1.17

0.13

3.2

3.1

11.24

713.54

mg/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.07

0.09

1.2

1.3

—

(3022145) Colonoscopy Study observation

1.04

0.08

1.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.12

0.08

1.0

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.11

0.08

1.8

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.85

0.07

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

458

1.08

0.06

3.4

3.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

581

1.09

0.04

4.0

3.4

1.50

1.59

mmol/l

0.94

549

(40758558) Short blood count panel - Blood

138

1.02

0.00

5.1

6.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.95

0.00

8.0

4.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.0

—

1093.88

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

1.31

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

15.94

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

174.67

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.91

-0.00

2.3

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.2

—

2208.75

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.2

—

(3024928) Oxygen saturation in Venous blood

0.00

-0.00

0.0

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.8

—

9.37

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.92

-0.00

1.4

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

19.57

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.06

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

7.52

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

121.11

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.3

—

105.33

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.3

—

4.08

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

92.75

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.6

—

13.58

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

53.13

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_MAEMABROAD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_MAEMABROAD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: N14_MAEMABROAD – Haematosalpinx/Haematoma of broad ligament

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Haematosalpinx/Haematoma of broad ligament

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints